Quinidine Gluconate Tablet, Extended Release
NDC Package 71930-016-12
Package Information
Quinidine Gluconate (quinidine gluonate) tablets is conversion of atrial fibrillation/flutter In patients with symptomatic atrial fibrillation/flutter whose symptoms are not adequately controlled by measures that reduce the rate of ventricular response, quinidine gluconate is indicated as a means of restoring normal sinus rhythm. This formulation utilizes a tablet, extended release delivery system. Marketed by Eywa Pharma Inc, this product is identified by NDC 71930-016 and is authorized under FDA application ANDA212589.
Identification & Billing
- RxCUI: 852920 - quiNIDine gluconate 324 MG Extended Release Oral Tablet
- RxCUI: 852920 - quinidine gluconate 324 MG Extended Release Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71930 - Eywa Pharma Inc
- 71930-016 - Quinidine Gluconate
- 71930-016-12 - 100 TABLET, EXTENDED RELEASE in 1 BOTTLE
- 71930-016 - Quinidine Gluconate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71930-016-12 identifies a specific commercial package of 100 tablet, extended release in 1 bottle of Quinidine Gluconate, a human prescription drug labeled by Eywa Pharma Inc. This tablet, extended release is formulated for oral use and contains quinidine gluconate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Eywa Pharma Inc on March 20, 2022. The current certification is valid through December 31, 2026.
How is this Eywa Pharma Inc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71930001612. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.